Is Mesoblast Limited overvalued?

Mesoblast Limited (MESO) — key valuation metrics and fundamentals.

No verdict

Price

$15.60

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.02B

Dividend yield

0.0%

Return on equity

-16.1%

Sector

Healthcare

Fair value compares MESO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks